Guangzhou Xiangxue Pharmaceutical Co.,Ltd. Posted 507.9 Million Yuan Net Loss in 2022

Guangzhou Xiangxue Pharmaceutical Co.,Ltd. (广州市香雪制药股份有限公司) (300147.SZ) reported a net loss of 507.9 million yuan in 2022, narrowing 22.9% year-on-year.

Meanwhile, the company posted 2.2 billion yuan in revenue, down 26.4% year-on-year.

At the end of the reporting period, it had 9.4 billion yuan in total assets and 6.5 billion yuan in total liabilities, with a liability-to-asset ratio of 69.9%.